Introduction and Objective: Adults with T2D not treated with insulin face distinct and ongoing self-management challenges. This qualitative study explored how CGM versus routine care (RC, without CGM) impacts psychological, behavioral, and emotional outcomes in this population. Methods: Semi-structured interviews were conducted virtually with a randomly selected subset of participants from the CONNECT randomized trial at month 6 of the 12-month study. By this time, participants in the CGM arm had been using real-time CGM for six months, while RC participants had continued without CGM. Interviews were recorded, transcribed verbatim, and analyzed using content and thematic analyses. Multiple coders independently reviewed the transcripts to ensure analytical rigor and validity. Results: Thirty adults participated in interviews (CGM: n=15, mean age=65 SD=7, 60% male; RC: n=15, mean age=54 SD=14, 60% male). Three primary themes emerged: 1) Real-time, actionable feedback: CGM supported more confident, data-driven decisions, while RC involved guesswork and difficulty linking actions to outcomes; 2) Behavioral and 3) Psychological Current; Dexcom, Inc. H. Singh: Employee; Current; Dexcom, Inc. N.N. Cadet: Stock/Shareholder; Current; Dexcom, Inc. T. Oser: Consultant; Ended; Dexcom, Inc. Research Support; Current; Dexcom, Inc. Advisory Panel; Current; Abbott Diabetes. Consultant; Ended; Medscape. Research Support; Current; Abbott Diabetes. Research Support; Ended; Insulet Corporation. R.W. Beck: Research Support; Current; MannKind Corporation, Abbott Diabetes, Dexcom, Inc., Tandem Diabetes Care, Inc., Sequel Med Tech, DreaMed Diabetes, Ltd. Consultant; Ended; Novo Nordisk, Eli Lilly and Company. Consultant; Current; Zucara Therapeutics.
GOPISETTY et al. (Sat,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: